Abstract
Energy intensive and chemical routes predominately govern modern dental material fabrication involving complex physicochemical approaches. Current interest in dental material design is shifting towards biomineralization method and green chemistry synthesis to support oral tissue biocompatibility and oropharmacology. This review article describes the context of biophysical approaches based on development in nanoengineering to design advance nanomaterials for clinical dentistry. We particularly focus on approaches governing surface texture and hierarchical assembly emphasis based on micro-nanoscale tooth anatomy. Further, this article provides an overview about the merit of micro-nanoscale material design techniques exchanging the traditional dental material. In this context, top-down and bottom-up approaches involving biomimetic nanoengineering route, opportunities and challenges are discussed.
Keywords: Dental materials, nanocomposites, DEJ, biomimetic, cement, colloidal platinum nanoparticles, biomineralization, membrane invested vesicles, GEPIs, odontoblast.
Current Pharmaceutical Design
Title:Top-Down Versus Bottom-Up Nanoengineering Routes to Design Advanced Oropharmacological Products
Volume: 22 Issue: 11
Author(s): Ajay V. Singh and Krunal K. Mehta
Affiliation:
Keywords: Dental materials, nanocomposites, DEJ, biomimetic, cement, colloidal platinum nanoparticles, biomineralization, membrane invested vesicles, GEPIs, odontoblast.
Abstract: Energy intensive and chemical routes predominately govern modern dental material fabrication involving complex physicochemical approaches. Current interest in dental material design is shifting towards biomineralization method and green chemistry synthesis to support oral tissue biocompatibility and oropharmacology. This review article describes the context of biophysical approaches based on development in nanoengineering to design advance nanomaterials for clinical dentistry. We particularly focus on approaches governing surface texture and hierarchical assembly emphasis based on micro-nanoscale tooth anatomy. Further, this article provides an overview about the merit of micro-nanoscale material design techniques exchanging the traditional dental material. In this context, top-down and bottom-up approaches involving biomimetic nanoengineering route, opportunities and challenges are discussed.
Export Options
About this article
Cite this article as:
Singh V. Ajay and Mehta K. Krunal, Top-Down Versus Bottom-Up Nanoengineering Routes to Design Advanced Oropharmacological Products, Current Pharmaceutical Design 2016; 22 (11) . https://dx.doi.org/10.2174/1381612822666151210124001
DOI https://dx.doi.org/10.2174/1381612822666151210124001 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Glance Over the Cannabinoid Machinery to Design New Anti- Angiogenic Compounds
Mini-Reviews in Medicinal Chemistry Association of Oxidative Stress to the Genesis of Anxiety: Implications for Possible Therapeutic Interventions
Current Neuropharmacology P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Current Cancer Drug Targets Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics Adult Neurogenic and Antidepressant Effects of Adiponectin: A Potential Replacement for Exercise
CNS & Neurological Disorders - Drug Targets GqPCR-mediated Signalling in the Spotlight: From Visualization Towards Dissection and Quantification
Current Pharmaceutical Biotechnology Recent Advances in Validating MDM2 as a Cancer Target
Anti-Cancer Agents in Medicinal Chemistry Involvement of Uridine-Nucleotide-Stimulated P2Y Receptors in Neuronal Growth and Function
Central Nervous System Agents in Medicinal Chemistry Calcium Channel Subtypes and Exocytosis in Chromaffin Cells at Early Life
Current Molecular Pharmacology Dimebon Attenuates the Aβ-Induced Mitochondrial Permeabilization
Current Alzheimer Research Development of PET Probes for Cancer Imaging
Current Topics in Medicinal Chemistry Mechanisms of Tau Self-Aggregation and Neurotoxicity
Current Alzheimer Research Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Current Pharmaceutical Design Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Current Cancer Therapy Reviews Antiglucocorticoids, Neurogenesis and Depression
Mini-Reviews in Medicinal Chemistry Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure
Current Drug Targets